Patent details
EP1175224 Title: PEGYLATED INTERFERON ALFA-CCR5 ANTAGONIST COMBINATION HIV THERAPY
Basic Information
- Publication number:
- EP1175224
- PCT Application Number:
- PCT/US/2000/011634
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP009286048
- PCT Publication Number:
- WO/2000/066141
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PEGYLATED INTERFERON ALFA-CCR5 ANTAGONIST COMBINATION HIV THERAPY
- French Title of Invention:
- PHARMACOTHERAPIE ANTI-VIH UTILISANT UNE COMBINAISON D'UN PEG-INTERFERON-ALPHA ET D'UN ANTAGONISTE CCR5
- German Title of Invention:
- PEGYLIERTES INTERFERON ALPHA IN KOMBINATION MIT EINEM CCR5 ANTAGONISTEN FÜR EINE HIV THERAPIE
- SPC Number:
Dates
- Filing date:
- 01/05/2000
- Grant date:
- 23/02/2005
- EP Publication Date:
- 23/02/2005
- PCT Publication Date:
- 09/11/2000
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/01/2002
- EP B1 Publication Date:
- 23/02/2005
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 01/05/2011
- Expiration date:
- 01/05/2020
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/05/2000
- Name:
- SCHERING CORPORATION
- Address:
- 2000 Galloping Hill Road, Kenilworth, New Jersey 07033-0530, United States (US)
Agent
- Name:
- SPEICH STEPHANE
- From:
- 11/02/2005
- Address:
- RUE DES BRUYERES 55, 1274, HOWALD, Luxembourg (LU)
- To:
Inventor
- Name:
- LAUGHLIN Mark, A.
- Address:
- United States (US)
Priority
- Priority Number:
- 304897
- Priority Date:
- 04/05/1999
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/21;
| Filing date | Document type | Number of pages |
|---|